Plain-English translation of NCT07239947 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atopic Dermatitis research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage trial testing a new medication called to see if it's safe and whether it helps people with moderate to severe atopic dermatitis (eczema). The trial has two parts: first, healthy volunteers receive a single dose to check for safety, then patients with eczema receive multiple doses over time to see if the medication improves their symptoms.
Many people with severe eczema don't get enough relief from current treatments like creams and lotions. This trial is exploring whether this new medication can offer a better treatment option by targeting the underlying causes of severe eczema.
You likely qualify if…
You likely don't qualify if…
If you're in the healthy volunteer part, you'll receive a single dose of the medication or placebo (a dummy treatment) and have your health monitored. If you're a patient with severe eczema, you'll visit the clinic multiple times over several weeks to receive seven doses of the medication or placebo, with blood tests and skin assessments at each visit to track how you're responding and check for any side effects.
AI-generated summary from trial data · Aug 2, 2026 · Not medical advice
China